Post Transplant Donor Lymphocyte Infusion The purpose of this study is to test the hypothesis that a pre-infusion preparative regimen of cyclophosphamide and fludarabine will improve the effectiveness of DLI in patients with blood...

• Country United States
• organs None
• Specialty None

Dexmedetomidine in Children Having Transthoracic Echocardiography Sedation Techniques for children undergoing transthoracic echocardiography (TTE).

• Country China
• organs None
• Specialty None

Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors Study 1493-852A is a phase 1 study with the primary objective of determining safety and the highest tolerated dose of an experimental immune response modifier administered intravenously to...

• Country None
• organs None
• Specialty None

Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers RATIONALE: Giving chemotherapy, natural killer cells, aldesleukin, and total-body irradiation before a donor umbilical cord blood stem cell transplant helps stop the growth of abnormal cel...

• Country None
• organs None
• Specialty None

Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia In this study our hypothesis is that infusion of donor lymphocyte immune cells from the subject's bone marrow donor will activate the subject's immune system to attack their cancer.

• Country None
• organs None
• Specialty None

Vaccination With Tetanus and KLH to Assess Immune Responses The purpose of this study is to learn how the immune system works in response to vaccines. We will give the vaccines to subjects who have cancer but have not had treatment, and to patients...

• Country None
• organs None
• Specialty None

MT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML Patients A phase II trial of CD3/CD19 depleted, IL-15 activated, donor natural killer (NK) cells in adults and subcutaneous IL-15 given after a preparative regimen for the treatment of relapsed or ...

• Country United States
• organs None
• Specialty None